Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan dual therapy vs bismuth quadruple therapy for Helicobacter pylori eradication
ChiCTR2200055752Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Xiamen University
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of vonoprazan in Helicobacter pylori infection (2 arms), sponsored by First Affiliated Hospital of Xiamen University. Primary endpoint: Helicobacter pylori eradication by 13C-urea breath test (13C-UBT). Started Nov 2021; status: recruiting.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2200055752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055752.